The big news this week has been the risk of cerebral venous sinus thrombosis post-AZ vaccine and it's been giving us all a headache, but this has overshadowed further new data confirming benefit of inhaled corticosteroids for acute mild covid and guidance that we can offer this to older patients on a case-by-case basis.

In the latest Hot Topics podcast Neal Tucker discusses the facts, figures, management and ethics of post-AZ vaccine thrombosis, reviews the Principle trial showing we now have a viable treatment for mild covid; and data on the rate of multi-organ dysfunction and death at 4 months post-hospital discharge for covid.

References
MHRA data on AZ vaccine and thrombosis risk
CDC Data on Johnson&Johnson vaccine and thrombosis risk
CDC Data on Transmission Reduction
STOIC trial Lancet Resp
Principle trial
NHS recommendations from the Principle trial data
BMJ post-covid syndrome data
UnHerd Did I Give My Patients COVID?

www.nbmedical.com/podcast